This white paper explores what agentic AI means for the specialty pharma access function, why the current moment represents a genuine inflection point, and how Claritas Rx’s Ask Ascend capability demonstrates what intelligent, agentic access analytics looks like in practice, live today.
What You’ll Learn:
- The three waves of AI in pharma, and why agentic AI is categorically different from predictive or generative tools
- The real cost of data fragmentation across hub, specialty pharmacy, and payer sources, including reporting latency, analyst dependency, and manual reconciliation burden
- The four capabilities that define a genuine agentic AI system: reasoning, retrieval, synthesis, and iteration
- A six-point framework for evaluating agentic AI vendors in the specialty pharma access space
